JP
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
Application Note
Enhance PROTAC Drug Discovery with AlphaLISA and HTRF Kits
A Bruton Tyrosine Kinase (BTK) case study
PROteolysis Targeting Chimeras (PROTACs) are one of the latest trending tools used in drug discovery.
This note compiles experiments carried out to characterize PROTAC compounds using Bruton Tyrosine Kinase (BTK) as a model on Ramos cells. Both AlphaLISA and HTRF technologies were used in biochemical and cell-based contexts.
Featured in this note:
- Assay principle and workflow
- Consistent results (data and graphs)
- Informative materials and methods, including references
For research use only. Not for use in diagnostic procedures.
To view the full content please answer a few questions
Download Resource
Enhance PROTAC Drug Discovery with AlphaLISA and HTRF Kits